Sodium hypochlorite, 362, 368
Solid-organ transplant (SOT), 387
clinical syndromes
bacteria, 392–394
bloodstream infections, catheter-related
infections, and infective endocarditis,
403–404
fever, noninfectious causes of, 405
fever of unknown origin, 404–405
fungal, 394–395
gastrointestinal infections, 398–400
neurological focality, 400–402
pneumonia, 391–392
postsurgical infections, 397–398
urinary tract infections, 398
viral, 395–397
diagnostic approach, 405–406
febrile processes of SOT recipients in ICU,
407–408
management of, 406–407
prevention, 408
recipients, most common infections in, 388
type of and time after, influence of, 387
anamnesis and physical examination, 390–391
appearance of infection and, time of, 389–390
underlying disease and, 388–389
SOT.SeeSolid-organ transplant (SOT)
SPEP.SeeSerum protein electrophoresis (SPEP)
Spirochetal infections, 157
Spirochetes, 158
Spleen, 350
Splenectomy, 352
Splenic abscess
clinical and radiologic diagnosis of, 81–82
mimics of, 82
Splenomegaly, physical findings
diagnostic features, 59
noninfectious mimics, 59
Spondyloarthropathy, 377
Spontaneous bacterial empyema, 346–347
Spontaneous bacterial peritonitis (SBP), 265–267
diagnosis of, 343
pathogenesis, 342–343
prophylaxis, 344
treatment of, 343–344
SPS.SeeSulfopolyanetholsulfonate (SPS)
SSI.SeeSurgical site infections (SSI)
SSSS.SeeStaphylococcal scalded skin syndrome
(SSSS)
St. Louis encephalitis virus, 33
Staghorn calculus, in pelvis
CT scan of abdomen, 77
Standard precautions, 466
for hospitalized patient, 21
in nosocomial infections, 433
Staphylococcus aureus, 549
Staphylococcal pneumonia, 94
Staphylococcal bacteremias
antimicrobial therapy for, 506
Staphylococcal cassette chromosome mec
(SCCmec), 103
Staphylococcal scalded skin syndrome (SSSS),
34–35, 311–312
diagnosis of, 35
generalized form of, 35
mortality rate in children, 35
Staphylococcal TSS, 33–34
clinical presentation of, 33
diagnosis of, 34
with toxin-producing bacteria, 33
Staphylococcus aureus, 76, 94, 135, 271, 277, 342, 392,
403.See alsoMethicillin-resistantS. aureus
(MRSA); Methicillin susceptibleS. aureus
(MSSA)
bacteremia, 38
burn wound infection, 362, 363
CAP and, 168, 170
in IE, 220–221, 222, 234, 239
antibiotic therapy of, 242–245
MSSA/MRSA ABE, 210–214
pneumonia due to, 181
skin and soft tissue infections and, 295, 296, 311
cellulitis, 298
impetigo, 297
necrotizing fasciitis (NF), 302
pyomyositis, 308
Staphylococcus epidermidis(CONS), 208
in IE, 221
Staphylococcus lugdunensis
in IE, 221
Staphylococcus sciuri, 103
Stenotrophomonas maltophilia, 180
Steroids, 150
Stevens–Johnson syndrome, 31, 74, 547
Still’s disease, 378
Stool, 116
culture and CDI diagnosis, 278
Coagulase negative staphylococci (S. epider midis)
Straphyococcal bacteremias, 503
Streptococcal gangrene, 302
Streptococcal pyrogenic exotoxin A/B/C
(Spe-A/B/C), 313
Streptococcal toxic shock syndrome (STSS), 304
Streptococcal TSS, 34
Streptococcus anginosus, 218, 220
Streptococcus bovis
in IE, 218, 220
Streptococcus constellatus, 220
Streptococcus faecalis
in IE, 222
Streptococcus gallolyticus, 498
Streptococcus intermedius, 218, 220
Streptococcus milleri, 218
Streptococcus mitis, 218
Streptococcus mutans, 218
Streptococcus pneumoniae, 164, 167, 170, 179, 326,
327, 342, 351, 378, 380, 392, 488
Streptococcus salivarius, 218
Streptococcus sanguisI/II, 218
skin and soft tissue infections and, 295–296
Streptomycin
for pneumonic tularemia, 479578 Index